Tags: Drug.

Otlertuzumab is a humanized monoclonal antibody designed for the treatment of cancer.This drug was developed by Emergent BioSolutions.

ATC prefix
none
CAS number
1372645-37-8

Loading...

This page contains content from the copyrighted Wikipedia article "Otlertuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.